112 related articles for article (PubMed ID: 3610710)
61. Optimization of perfluorochemical levels with radiation therapy in mice.
Teicher BA; Herman TS; Jones SM
Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
[TBL] [Abstract][Full Text] [Related]
62. Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice.
Greer S; Alvarez M; Mas M; Wozniak C; Arnold D; Knapinska A; Norris C; Burk R; Aller A; Dauphinée M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):791-806. PubMed ID: 11697326
[TBL] [Abstract][Full Text] [Related]
63. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
64. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Goldfeder A; Brown DM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
[TBL] [Abstract][Full Text] [Related]
65. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Herman TS; Teicher BA; Coleman CN
Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
[TBL] [Abstract][Full Text] [Related]
66. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.
Rupnow BA; Murtha AD; Alarcon RM; Giaccia AJ; Knox SJ
Cancer Res; 1998 May; 58(9):1779-84. PubMed ID: 9581811
[TBL] [Abstract][Full Text] [Related]
67. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Sheldon PW; Hill SA; Foster JL; Fowler JF
Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
[TBL] [Abstract][Full Text] [Related]
68. Laser dyes for experimental phototherapy of human cancer: comparison of three rhodamines.
Haghighat S; Castro DJ; Lufkin RB; Fetterman HR; Castro DJ; Soudant J; Ward PH; Saxton RE
Laryngoscope; 1992 Jan; 102(1):81-7. PubMed ID: 1731162
[TBL] [Abstract][Full Text] [Related]
69. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
70. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
71. Enhancement of radiation response by paclitaxel in mice according to different treatment schedules.
Cividalli A; Arcangeli G; Cruciani G; Livdi E; Cordelli E; Danesi DT
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1163-70. PubMed ID: 9539573
[TBL] [Abstract][Full Text] [Related]
72. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
73. Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation.
Greer S; Schwade J; Marion HS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1059-69. PubMed ID: 7607927
[TBL] [Abstract][Full Text] [Related]
74. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
75. [Intraarterial infusion of hypoxic radiosensitizer RK28 in rabbit VX2 tumor system].
Suda H
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jun; 51(6):678-85. PubMed ID: 1886757
[TBL] [Abstract][Full Text] [Related]
76. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
77. [Experimental studies on the combined effect of radiation and UFT 1. Radiosensitizing effect of UFT under single X-ray exposure].
Yamakawa M; Niibe H; Honjo J; Kazumoto T; Akimoto T; Furuta M; Yonome I; Kawaharada U
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3443-7. PubMed ID: 2508568
[TBL] [Abstract][Full Text] [Related]
78. In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas.
Matsuoka H; Shibamoto Y; Kubota T; Tsujitani M; Majima T
Oncol Rep; 2000; 7(1):23-6. PubMed ID: 10601585
[TBL] [Abstract][Full Text] [Related]
79. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821
[TBL] [Abstract][Full Text] [Related]
80. Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.
McKeown SR; Friery OP; McIntyre IA; Hejmadi MV; Patterson LH; Hirst DG
Br J Cancer Suppl; 1996 Jul; 27():S39-42. PubMed ID: 8763843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]